Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) EBIAT (2016 - 2023)

Historic EBIAT for Cellectis (CLLS) over the last 10 years, with Q3 2023 value amounting to -$58.2 million.

  • Cellectis' EBIAT rose 2663.57% to -$58.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$133.5 million, marking a year-over-year increase of 767.3%. This contributed to the annual value of -$106.1 million for FY2022, which is 20716.84% down from last year.
  • Per Cellectis' latest filing, its EBIAT stood at -$58.2 million for Q3 2023, which was up 2663.57% from -$16.6 million recorded in Q2 2023.
  • In the past 5 years, Cellectis' EBIAT ranged from a high of $46.7 million in Q4 2020 and a low of -$89.2 million during Q3 2021
  • Over the past 5 years, Cellectis' median EBIAT value was -$35.9 million (recorded in 2020), while the average stood at -$32.2 million.
  • In the last 5 years, Cellectis' EBIAT skyrocketed by 23169.6% in 2020 and then tumbled by 37687.95% in 2023.
  • Over the past 5 years, Cellectis' EBIAT (Quarter) stood at -$41.2 million in 2019, then surged by 213.54% to $46.7 million in 2020, then tumbled by 117.28% to -$8.1 million in 2021, then crashed by 253.76% to -$28.6 million in 2022, then crashed by 103.78% to -$58.2 million in 2023.
  • Its last three reported values are -$58.2 million in Q3 2023, -$16.6 million for Q2 2023, and -$30.1 million during Q1 2023.